Screening of newly-diagnosed adults with Tuberculosis for Diabetes mellitus and Impaired Glucose Tolerance in a Local Government Area in Ogun State, Nigeria

  • AA Salako
  • OA Adenowo
  • O Amoran
  • O Odusan
  • JG Mautin
  • F Sanya-Isijola
Keywords: Diabetes mellitus, Directly-Observed Therapy Short Course, Screening


Background: Emerging patterns in epidemiological transitions have led to increased risk for Non-Communicable Diseases and infectious conditions globally. Diabetes mellitus (DM) in a population is one such risk factor that could lead to the development of Tuberculosis (TB) due to weakened immune functions in affected persons, with implications for mortality. If not diagnosed early, DM also leads to poor treatment outcomes in TB.

Objective: To assess the prevalence of DM and impaired glucose tolerance (pre-diabetes) among newly diagnosed tuberculosis cases in Ijebu-Ode Local Government Area of Ogun State, Nigeria.

Methods: This cross-sectional study was conducted among 100 newly diagnosed Pulmonary TB patients in ljebu-Ode LGA. The patients were selected from four health facilities and were screened for elevated Fasting Blood Glucose levels using a laboratory spectrophotometer (glucose oxidase method).

Results: The mean age of the 100 study participants was 33 years (± 9.82), with ages within 19 -62 years. Eleven (11.0%) had elevated blood glucose levels suggestive of DM, while 20 (20.0%) had impaired fasting blood glucose levels. Among these 31 patients, 18 (58.0%) were males while 13 (42.0%) were females. The modal ages were within 20-39 years.

Conclusion: Screening for DM by healthcare providers should be routinely conducted before commencing TB patients on treatment. This will aid early detection, improve treatment outcomes of TB and prevent mortality among patients with these co-morbidities.


Adogu POU, Ubajaka CF., Emelumadu OF., Alutu COC. Epidemiologic Transition of Diseases and Health-Related Events in Developing Countries: A Review, Am J Med Sci 2015; 5(2): 150-157.

Enrico G, Monica SS, Delia G, Matthew B, Peter M, Dorothy YM, et al. The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. Int J Infect Dis 2017; 56: 45–53.

Joao DRF, Katherine O, Ute L, Leonor G, Till S, Ping Z, David C, Lydia EM. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 2016; 11(7): 48–4.

WHO. Global Tuberculosis Control Report 2018: 30- 31.

World Health Organization Diabetes Fact Sheets 2018.

Kegne AP, Amoah AG, Mbanya JC. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation AHA 2005; 112(23): 3592–3601.

International Diabetes Federation (IDF) Diabetes Atlas. 2017.

Nasheeta P, Kegne AP, Motala AA, Mbanya JC. Diabetes in the African Region: an update. Diabetes Res Clin Pract 2014; 103(2): 197-205.

WHO Global Report on Diabetes. 2016:6.

Ogbera AO, Ekpebegh C. Diabetes Mellitus in Nigeria: The past, present and future. World J Diabetes 2014; 5(6): 905-911.

Tukur D, Alhaji A, Shehu AU. A review of population based studies on diabetes mellitus in Nigeria, Sub-Saharan Afr J Med 2016; 3(2): 59-64.

Geerlings SE, Hoepelman Al. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26(3-4): 259-265.

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5(7): 1091–1101.

Victoria H, Reimar WT, Ole H, Nicholai L. Diabetes in Sub Saharan Africa 1999-2011, Epidemiology and public health implications, a systematic review. BMC Public Health 2011; 11: 564.

Fiona Y, Julia C, Lucy J, Nigel U. A review of co-morbidity between infectious and chronic diseases in Sub Saharan Africa: TB and Diabetes mellitus, HIV and Metabolic Syndrome, and the impact of globalization. BMC Globalisation Health 2009; 5(9).

Restrepo BI, Camerlin AJ, Rahbar MH, Wang W, Restrepo MA, Susan FH, et al. Cross-sectional assessment reveals high diabetes prevalence among newly diagnosed tuberculosis cases. Bull World Health Org 2011; 89(5): 352-359.

Satyavani K, Vijay V. Diabetes and Tuberculosis- a co-epidemic of public health importance in the developing world. J Current Sci 2017; 113(7).

Mahteme HW, Gunner AB, Solomon AY. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One 2017; 12 (4).

Kelly D, Richard EC. Tuberculosis and Diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9(12): 737–746.

National Population Commission. Population distribution tables by Sex, State, LGA and Senatorial district, (Updated 2010). Population and Housing Census 2006, Nigeria.

WHO. WHO definition and diagnosis of diabetes mellitus and intermediate glycaemia: report of a WHO/IDF consultation. Geneva: 2006.

Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem 1966; 6 ; 24.

Olayinka AO, Anthonia O, Yetunde K. Prevalence of diabetes mellitus in persons with tuberculosis in a tertiary health center in Lagos, Nigeria. Indian Journal of Endocr Metab. 2013; 17(3):486-489.

Animut A, Amsalu W. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis 2019, 19:254.

Mkhontfo, Mandzisi Mbongeni. An Examination of the Distribution of Diabetes Mellitus among TB Patients with Pulmonary Tuberculosis and Drug-Resistant Tuberculosis in the State Of Florida, USA. (2016). Graduate Theses and Dissertations. Available at Accessed on October 5, 2018.

Ogbera AO, Kapur A, Odeyemi K et al. Screening for diabetes Mellitus and human immunodeficiency virus infection in persons with tuberculosis. J Prev Med Hyg 2014; 55(2): 42-45.

Magna MA, Subrata KP, Subhashisa S, Sandipana P, Sanghamitra P. Diabetes Mellitus among Newly Diagnosed Tuberculosis Patients in Tribal Odisha: An Exploratory Study. J Clin Diagn Res 2016; 10(10): 06–08.

Tanzila T. A survey on the prevalence of diabetes in tuberculosis patients in NIDCH hospital, Dhaka. EWU Repos, 2016. Available at Accessed on 22nd September 2018.

Assefa G, Solomon M, Shiatye A, Hanan Y. High magnitude of diabetes mellitus among Active Pulmonary Tuberculosis Patients in Ethiopia. BR J Med Med Res, 2014, 4(3): 862-872.

Shugang L, Shuxia G, Fei H, Mei Z, Jia H, Yizhong Y, et al. Prevalence of Diabetes Mellitus and Impaired Fasting Glucose, Associated with Risk Factors in Rural Kazakh Adults in Xinjiang, China. Int J Environ Res Pub Health 2015; 12(1): 554-565.

Lawson L, Muc M, Oladimeji O, Iweha C, Opoola B, Abdurhaman ST, et al. Tuberculosis and diabetes in Nigerian patients with and without HIV. Int J Infect Dis 2017; 61: 121–125.

UNGA Third UN level high meeting on Non-Communicable Diseases 2018.

Ben JM, Knut L, Stephen DL, Giovanni BM, Peter M, Philippe G, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 2013; 13(5): 436-448.

Original Research